Expansion of necrotic core (NC), a major feature responsible for plaque disruption, is likely the consequence of accelerated macrophage apoptosis coupled with defective phagocytic clearance (efferocytosis). The cleavage of the extracellular domain of Mer tyrosine kinase (Mertk) by metallopeptidase domain17 (Adam17) has been shown to produce a soluble Mertk protein (sMer), which can inhibit efferocytosis. Herein, we analysed the expression and localization of Mertk and Adam17 in the tissue around the necrotic core (TANC) and in the periphery (P) of human carotid plaques. Then we studied the mechanisms of NC expansion by evaluating which components of TANC induce Adam17 and the related cleavage of the extracellular domain of Mertk.
Introduction
Observational studies have shown that apoptotic macrophages accumulate in advanced atherosclerotic lesions. 1 When phagocytes cannot dispose of the apoptotic cells in a rapid and efficient manner, these apoptotic macrophages become secondarily necrotic and coalesce over time into a key feature of vulnerable plaque, the necrotic core (NC). 2, 3 Expansion of NC is likely the consequence of accelerated macrophages apoptosis coupled with defective phagocytic clearance, a process called defective efferocytosis. 2, 3 NC is a major feature responsible for plaque disruption and acute luminal thrombosis. 4 Tyro3, Axl, and Mer tyrosine kinase (Mertk) (TAM receptors) are surface receptors that have been implicated in the process of apoptotic cell recognition and engulfment. 5 The Mertk is believed to play a primary role as a phagocytic receptor for macrophage apoptotic cells. 6 -8 The principal ligand for TAM receptors is the growth arrestspecific gene 6 (Gas6), a member of the vitamin K-dependent protein family. 9 Gas6 binds to phosphatidylserine on the outer membrane of apoptotic cells and serves as a bridging molecule between TAM receptors on phagocytes and apoptotic cells. 10 Recently, direct evidence of the effect of Gas6/TAM system on mouse atherosclerosis has been shown in Gas6 and Mertk knockout mice crossed with ApoE 2/2 and/or LDLr 2/2 strains. 11, 12 Furthermore Sather et al. 13 have found that the membrane-bound Mertk protein in macrophage cell lines is cleaved in the extracellular domain via a metalloproteinase with the production of a soluble Mertk (sMer) protein. sMer can act as a competitive inhibitor of Mertk by acting as a decoy for its ligand Gas6. 13 As for the mechanism of sMer production, Thorp et al. 14 have recently demonstrated that shedding of Mertk in murine macrophages is induced by lipopolysaccharide (LPS), and it is mediated by the metallopeptidase domain 17 (Adam17), otherwise known as tumour necrosis factor-a-converting enzyme. 15 Since the defective efferocytosis in the tissue around NC (TANC) has been suggested to play a key role in the expansion of NC, 2,3 the first aim of this study was to analyse TAM receptors, Gas6, and Adam17 expression in TANC and in the periphery (P) of the same human carotid plaques. Because the immunohistochemical quantification of Mertk in TANC showed progressively lower expression from the lumen towards the NC, in order to verify if this unexpected result was due to the cleavage of its extracellular domain, we studied the effect of TANC extract on the expression of Adam17 and Mertk and on the shedding of its soluble ectodomain sMer in macrophage-like THP-1 cells. Finally, we analysed the components of TANC extract and found that 8-iso-prostaglandin-F 2a (8-iso), 15-hydroxyeicosatetraenoic acid (15-HETE), and 9-hydroxyoctadecadienoic acid (9-HODE) increased the expression of Adam17 and the shedding of the soluble ectodomain of Mertk by binding to specific receptors.
Methods
All the investigations conform to the Declaration of Helsinki. The study was approved by the Ethical Committee of University of Verona and all participants provided written consent.
Collection of human specimens
We collected 97 carotid plaque specimens from 107 asymptomatic consecutive patients undergoing carotid endarterectomy according to present guidelines. 16 After removal from the carotid artery, the plaques were placed in chelex-100-treated PBS containing EDTA (0.75 mg/mL), BHT (0.02 mg/mL), and RNA stabilization reagent (RNALater, Qiagen, Hilden, Germany). The plaques were examined macroscopically to individualize the site of the maximum plaque thickening and then transversely dissected into two segments. One of the two segments was further dissected in three specimens for histology, immunohistochemistry, and protein expression; the other segment was used to prepare TANC and P extracts. In brief, after removing NC, the segment close to NC was used to obtain TANC extract, while P was derived from the periphery of the same human carotid plaque. The segments were blotted dry and immediately stored at 2808C. Normal arteries (NA) were collected from 10 patients undergoing splenectomy.
Histology and immunohistochemistry
Segments for histology and immunohistochemistry were fixed in paraformaldehyde 4% for 2 -4 h and embedded in paraffin. Sections of each segment were stained with haematoxylin -eosin for histological analysis to evaluate NC size, fibrous cap thickness and rupture, and presence of calcification. The carotid plaques were classified histologically as proposed by Virmani et al. 17 and endorsed by Stary. 18 In this study, only carotid plaques with a fibrous cap atheroma or a thin fibrous cap atheroma, markedly infiltrated by macrophages and an underlying NC were taken into consideration (n ¼ 34). Details of the main characteristics of the patients undergoing endarterectomy and of the plaques considered are described in Table 1 . For immunostainings of CD68 positive cells, Mertk and Adam17, before immunolabelling, sections were deparaffinized, rehydrated, and treated in a microwave oven in 10 mM sodium citrate buffer, pH 6.0. Endogenous peroxidase activity was blocked by incubation with 3% H 2 O 2 in methanol for 30 min. Slices were incubated with 2% normal serum, 0.3% Triton X100, and 1% bovine serum albumin for 20 min and then with the following primary antibodies for 1 h at room temperature: CD68 (PG-M1, Dako, Aachen, Germany), Mertk (Y323, ab52968, Abcam Ltd, Cambridge, UK), and Adam17 (ab57484, Abcam Ltd, Cambridge, UK). The sections were then incubated with complementary secondary antibody for 1 h and then with avidin-biotin for 30 min. Diaminobenzidine was used as chromogen and sections were counterstained with haematoxylin. All images were assessed by image-Pro Plus software of BX60 Olympus microscope (Media Cybernetics Inc., Bethesda, MD, USA). Densitometric analysis of CD68 positive cells, Mertk and Adam17 immunostainings were obtained by AxioVision 4.6 (Carl Zeiss Spa, Milan, Italy). After immunostaining of Mertk and Adam17, each area of interest was divided into quintiles, the first quintile being close to the lumen. Pixel density (Grey Unit) of brown coloured proteins of each area was determined.
Preparation of NA, P, and TANC extracts
NA, P, and TANC segments, still frozen, were immediately placed in chelex-100-treated PBS buffer containing EDTA (0.75 mg/mL) and BHT (0.02 mg/mL). The samples were homogenized using an Ultra-Turrax T8 blade homogenizer (IKA Labortechnik, Staufen, Germany) for 5 min and the fine tissue powders derived from TANC and P of all plaques and from all normal spleen arteries were put together. The powder was extracted with water/methanol (1:1) containing EDTA (0.75 mg/mL) and BHT (0.02 mg/mL), aliquoted, frozen in liquid nitrogen and stored at 2808C as previously described. 19, 20 Since no hydrolysis of cholesterol ester and triglycerides was performed, only the free forms of oxidative derivatives of polyunsaturated fatty acids were extracted. 21 8-iso, 15-HETE, 9-HODE, and their deuterated internal standards were purchased from Cayman Chemical Company (Ann Arbor, MI, USA). All solvents used in the chromatography were of HPLC grade. The overall recovery of the extraction method was 54.3 + 4.5, 39.7 + 4.2, and 47.0 + 5.1% for 8-iso, 15-HETE, and 9-HODE, respectively.
Evaluation of components of TANC extract
Mass spectrometry (MS) analysis of TANC extract was performed on an ion trap mass spectrometer (model 1100, Agilent Technologies, Waldbronn, Germany); ions were generated with an Electrospray Ionization Source at 3508C, and spectra were acquired in the negative mode (total ion range 200 -400 m/z). Analytical evaluation of 8-iso, 15-HETE, and 9-HODE in TANC extract was performed by reverse-phase HPLC using an Alltech Vydac C 18 column (100 × 0.3 mm, 3 mm ODS) (Deerfield, IL, USA) equipped with a guard column at 378C; the sample was eluted in isocratic mode using methanol/ammonium acetate (10 nM) 95:5 vol:vol at a flow rate of 25 mL/min. The HPLC column effluent was introduced into the electrospray MS. Quantitation was achieved by relating the peak areas of 8-iso, 15-HETE, and 9-HODE with those of the Necrotic core expansion and oxidized fatty acids deuterated internal standards of the three different compounds (Cayman Chemical Co, Ann Arbor, MI, USA).
Cell cultures
Macrophage-like THP-1 cell line was cultured and differentiated as previously described. 22 Blood monocytes were isolated from buffy coats of healthy donors by Ficoll-Hypaque and Percoll (Amersham UK) density gradients as previously described. 23 THP-1 and primary human macrophages were incubated with NA, P, and TANC extracts to evaluate the expression of Adam17 and Mertk and the shedding of its soluble ectodomain sMer. Moreover in some experiments, THP-1 cells were preincubated with a TP receptor antagonist SQ29512 (50 -100 mM), G2A receptor-specific antibody (2 mg/mL) (SC-9692, Santa Cruz, Heidelberg, Germany), or normal goat IgG (2 mg/mL) for 1 h, and incubated with TANC extract, 8-iso, and a mixture of 15-HETE and 9-HODE agonists. Early apoptosis and cell viability were determined using the AnnexinV-FITC Kit (Bender MedSystems GmbH, Vienna, Austria) and 7-amino-actinomycin D (7-AAD) (BD Biosciences, Buccinasco, Italy) by flow cytometry. Endotoxin contamination of cell cultures was routinely excluded with the chromogenic Limulus amebocyte lysate assay (Sigma-Aldrich, Milan, Italy).
RNA isolation and quantitative real-time PCR
Total RNA was isolated with QIAzol Lysis reagent and RNEasy Mini Kit (Qiagen, Hilden, Germany). The concentration and quality of RNA were evaluated using the RNA 6000 Nano LabChip Kit (Agilent 2100 Bioanalyzer; Agilent Technologies Inc., Santa Clara, CA, USA). Reverse transcription of total RNA was carried out using IScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer's recommendations. The relative expression levels of genes of interest (Adam17, Mertk, Axl, Tyro3, and Gas6) were performed in triplicate using QuantiTect Primer Assay and QuantiTect SYBR Green PCR Kit (Qiagen, Hilden, Germany) on the MyiQ Thermal Cycler (Bio-Rad, Hercules, CA, USA) as previously described. 24 QuantiTect Hs-ACTB Assay (Qiagen, Hilden, Germany) was used as normalizer.
siRNA-mediated knockdown of Adam17
The two validated silencing RNA (siRNA) sequence targeting Hs_Adam17 were purchased from Qiagen, (Hilden, Germany) (SI02664501 and SI02664508) together with the fluorescein-labelled non-silencing siRNA (AllStars Negative Control 1027282). Transfection was performed in 24-well plates using HiPerfect Transfection Reagent (Qiagen, Hilden, Germany), according to the manufacturer's instructions and as previously described. 24 
Western blotting analysis
Western blotting analysis was performed as described elsewhere. 22, 23 The following primary antibodies against the indicated proteins were used: Adam17 (ab57484), Axl C-terminal (ab72069), Tyro3 (ab79778), Mertk (MAB8911), Gas6 (AF885), sMer (MAB8911) (R&D Systems Inc., MN, USA), and beta-actin (SC-130656) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). As secondary antibodies, appropriate horseradish peroxidase-conjugated antibodies were used and the bands visualized according to a standard chemiluminescence protocol (Immobilon Western, Millipore, Billerica, MA, USA). Protein expression was quantified using VersaDoc Imaging System (Bio-Rad, Hercules, CA, USA).
Flow cytometry
Flow cytometry analysis was performed as previously described. 24 The following monoclonal antibodies were used: Mertk (Y323, b52968, Abcam Ltd, Cambridge, UK), Adam17 ectodomain (MAB9301, R&D Systems Inc., MN, USA). The cells were washed and incubated for 30 min with FITC-conjugated anti-rabbit and anti-mouse antibodies, respectively. Samples were analysed by flow cytometry using FACS Calibur (Becton Dickinson and Company Franklin Lakes, NJ, USA).
Other methods
Activity of ADAM17 and efferocytosis assay are described in Supplementary material online, Methods.
Statistical analysis
The data are presented as mean + SD. Significant differences among the groups were determined using two-tailed unpaired Student's t-test or one-way ANOVA and post-hoc multiple comparison using StudentNewmann -Keuls' test. A value of P , 0.05 was considered to be statistically significant.
Results

Expression of TAM receptors, Gas6
, and Adam17 in NA and in P and TANC of human carotid plaques Figure 1 shows the mRNA and protein expression of TAM receptors, Gas6, and Adam17 in normal artery and in carotid plaques. Among the TAM receptors only Mertk resulted significantly higher in Figure 3 Dose -response (20 and 40 mL/mL medium) effect of the extracts of normal artery (NA), periphery (P), and tissue around the necrotic core (TANC) on mRNA expression of Mertk and Adam17 after incubation with THP-1 cells for 6 (A) and 24 h (B). Normalized gene expression levels were given as the ratio between the mean value for the target gene and that for the beta-actin in each sample. Data represent the mean + SD of measurements performed in triplicate in six different occasions. *P , 0.01 vs. basal; † P , 0.01 vs. 20 mL.
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TANC than in NA and P (P , 0.001). Similarly, Adam17 but not Gas6, was higher in TANC than in NA and P (P , 0.001). Figure 2A shows macrophage CD68 positive areas. Figure 2B and C demonstrates the immunostainings of Mertk and Adam17 in TANC. In order to quantify Mertk and Adam17, TANC was divided into quintiles and the pixel density quantified. As shown in Figure 2D , Adam17 signal resulted more prevalent in the area near to NC while Mertk signal was more evident in the area close to the lumen (P , 0.01). The negative control immunostaining and the lower power magnification of Figure 2A -C are shown in Supplementary material online, Figure  SI and SII, respectively.
Immunohistochemical localization of Adam17 and Mertk in TANC of human carotid plaques
Effect of TANC extract on the expression of Mertk and Adam17 and on the shedding of extracellular domain of Mertk in THP-1 cells: role of Adam17
In order to understand if the trend of Mertk from the lumen to the NC was due to the cleavage of its extracellular domain by Adam17, we extracted TANC and used P and NA as controls. We first evaluated the dose-and time-dependent effect of these tissue extracts on mRNA and found that only TANC dose-dependently increased Mertk and Adam17 expression after 6 and 24 h (Figure 3) . Then we looked at the extracellular domain of both Mertk and Adam17 protein by flow cytometry. The incubation of THP-1 cells with TANC extract for 6 h determined a significant increase in the expression of both Mertk and Adam17 extracellular domain (P , 0.01). After 24 h of incubation with TANC extract, however, there was a further rise of Adam17 protein expression (P , 0.01) associated with that of Adam17 activity Necrotic core expansion and oxidized fatty acids (see Supplementary material online, Figure SIV) , while the extracellular domain of Mertk significantly reduced (P , 0.01) ( Figure 4A) . The reduction of extracellular domain of Mertk was partially inhibited when Adam17 gene was silenced by siRNA ( Figure 4B ), indicating that this enzyme may play an important role in Mertk inactivation. Similar results were obtained by using human primary macrophages (see Supplementary material online, Figure SIII) . In turn, the fall in the extracellular domain of Mertk was associated with the rise of sMer in the culture medium (P , 0.01) ( Figure 4C ). This increase was reduced when Adam17 gene was knockdowned by siRNA confirming the role of Adam17 in the cleavage of Mertk (P , 0.01) ( Figure 4D) . Efferocytosis bioassay shows that TANC extract increased the ratio of free-to-macrophage-associated THP-1 apoptotic cells (P , 0.01) (see Supplementary material online, Figure SV ).
Qualitative analysis of TANC extract components
A representative total ion chromatogram (obtained from direct injection of TANC extract) is shown in Figure 5 ; peaks correspond to 3.5 Effect of SQ29512 and of the pre-incubation with a G2A-specific antibody on the expression of Adam17 and on the shedding of extracellular domain of Mertk induced by TANC extract, 8-iso, and by a mixture of 15-HETE and 9-HODE in THP-1 cells
In order to verify if the effect of TANC extract on Adam17 expression and on the shedding of the extracellular domain of Mertk was related to the binding of 8-iso, 15-HETE, and 9-HODE to thromboxane A 2 (TP)-and G2A-receptors, respectively, SQ29592, a (TP)-receptor antagonist, and a G2A-specific antibody were used. SQ29592 dose-dependently reduced the expression of Adam17 (P , 0.01) and the shedding of the extracellular domain of Mertk (P , 0.01) induced by TANC extract and by 8-iso in THP-1 cells ( Figure 6A and B) . Similarly, the pre-incubation of THP-1 cells with a specific antibody against G2A receptor, but not with a control IgG, reduced the expression of Adam17 (P , 0.01) and the shedding of the extracellular domain of Mertk (P , 0.01) induced by TANC extract, and by a mixture of 15-HETE and 9-HODE ( Figure 6C and D) .
Discussion
Cellular biology and animal studies indicate a role of the Gas6-TAM pathway, and in particular, of Mertk as a phagocytic receptor for macrophage apoptotic cells. 5, 6, 25 In this study, we found that Mertk and Adam17 (mRNA and protein) were significantly more expressed in TANC than in P. However, when the two proteins were evaluated by immunohistochemistry, Mertk was expressed more than Adam17 in the area of TANC close to the lumen, while it was almost absent near to the NC. The reason why there is an opposite trend of these two proteins in this area is presently unclear. In animal studies it has been shown that the membrane-bound Mertk protein can be cleaved in the extracellular domain via Adam17. 15 So, even though on the basis of the present results we cannot draw any definite conclusion, one hypothesis could be that where the concentration of Adam17 is at the top there is a reduction of extracellular domain of Mertk in spite of the increased mRNA. This may mean that the tissue near to NC may contain some substances that may be strong inducers of Adam17, the enzyme in turn may release the extracellular domain of Mertk inactivating the receptor. The results we obtained in vitro by incubating TANC extract with THP-1 cells support this hypothesis. TANC extract (that tentatively was extracted from the same area where Adam17 was more expressed) time-dependently increased the expression of both Mertk and Adam17 after 6 and 24 h as well as the activity of Adam17. But, while the Adam17 protein was regularly expressed after 6 and 24 h, the extracellular domain of Mertk was reduced after 24 h of incubation with TANC extract and sMer in the culture medium was increased. These modifications were associated with a reduction of efferocytosis as evaluated in THP-1 cells by a bioassay. By silencing Adam17, the reduction of extracellular domain of Mertk was almost completely abolished, indicating that Adam17 may be one of the determinants of sMer generation and therefore of the inactivation of Mertk. This conclusion is in agreement with the results recently published by Thorp et al. 14 who reported that shedding of sMer in murine macrophages is induced by LPS via Adam17, and it is supported by the demonstration that Adam17 is the only known metalloproteinase responsible for the cleavage of extracellular domain of Mertk and Axl. 26 Our results, however, for the first time showed that shedding of sMer in THP-1 cells was evoked via Adam17 by some substances directly extracted from the tissue near to NC. TANC extract, in fact, is an LPS-free mixture of different compounds mostly containing oxidative derivatives of polyunsaturated fatty acids that reasonably resembles foam cell content. It derives from a mild extraction of TANC without ester hydrolysis and it is therefore representative only of the free forms of the substances contained in the tissue. 22 These substances and, in particular, progression of atherosclerotic lesions. 34 In this study, we showed that the effect of TANC extract on the expression of Adam17 and on the cleavage of the extracellular domain of Mertk in THP-1 cells was dose-dependently counteracted by SQ29512, a TP-receptor antagonist. To our knowledge, this is the first demonstration that some oxidative derivatives of arachidonic acid present in TANC increase Adam17 expression and the cleavage of the extracellular domain of Mertk by binding to TP receptors. In this context, TP-receptor inhibition has shown antiatherosclerotic effects in mice and rabbits. 35, 36 In a double-blind, parallel group study involving patients with a history of ischaemic stroke and/or carotid stenosis, terutroban, a TP-receptor antagonist, demonstrated antithrombotic activity superior to aspirin and similar to clopidogrel plus aspirin. 37 These findings, however,
were not confirmed in the large study PERFORM, where terutroban did not show any superiority over aspirin in secondary prevention of cerebrovascular and cardiovascular events among patients with ischaemic cerebrovascular disease. 38 Finally, in this study, we found that a mixture of HETEs and HODEs increased the expression of Adam17 and the shedding of the extracellular domain of Mertk and that this effect was dose-dependently inhibited by the pre-incubation of THP-1 cells with a G2A receptor-specific antibody. The G2A receptor is a G protein-coupled receptor that has been shown to function as a receptor for oxidized free fatty acids. 39 The G2A receptor was found to be highly expressed in THP-1 cells and in macrophages of atherosclerotic plaques both in humans and in apolipoprotein E-deficient mice. 40 Very interestingly, this inhibitory effect of G2A receptor antibody was also obtained when THP-1 cells were stimulated with TANC extract, suggesting that HETEs and HODEs contained in the carotid plaques may favour Adam17 expression and sMer generation.
In conclusion, the results of this study show that some compounds derived from the oxidation of polyunsaturated fatty acids and mostly contained in the tissue close to NC of human carotid plaques are strong inducers of Adam17, which in turn may cleave the extracellular domain of Mertk giving rise to sMer. The net result of this chain of events may be the inactivation of Mertk and the reduction of Gas6 availability that jointly promote defective efferocytosis favouring the expansion of the NC, a major feature responsible for plaque disruption and acute luminal thrombosis. Statins have recently been reported to induce favourable plaque morphological changes with an increase in fibrous cap thickness and a decrease in both percentage plaque and lipid volume indexes. 41 Furthermore, it has been shown that protein disulfide isomerase (PDI) maintains Adam17 in an inactive 'closed' state. Reactive oxygen species can alter the redox environment, which in turn inactivates PDI, allowing Adam17 to adopt an 'open' active conformation. 42 Further studies are needed to prove that statins and antioxidants can cause changes in plaque composition through an effect on Adam17.
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